clinical trials

Ionis reveals an oasis for HAE patients as RNA med reduces attacks in phase 3
Fierce Biotech
Fri, 05/31/24 - 11:00 am
Ionis Pharmaceuticals
HAE
clinical trials
donidalorsen
Novartis study points to larger role for targeted leukemia drug
BioPharma Dive
Fri, 05/31/24 - 10:50 am
Novartis
Scemblix
ASCO 2024
clinical trials
CML
Novartis cues up filings for remibrutinib in chronic hives
Pharmaphorum
Fri, 05/31/24 - 10:47 am
Novartis
remibrutinib
chronic hives
clinical trials
Ultragenyx Pharmaceutical Says Glycogen Storage Disease Treatment Met Endpoints
Marketwatch
Fri, 05/31/24 - 10:46 am
Ultragenyx
clinical trials
DTX401
glycogen storage disorder
Gilead’s Trodelvy suffers double whammy as failed bladder cancer trial raises flag over early deaths
Fierce Pharma
Thu, 05/30/24 - 11:17 pm
Gilead Sciences
clinical trials
Trodelvy
bladder cancer
BridgeBio Builds on Positive Phase III Data for Acoramidis in ATTR-CM
BioSpace
Thu, 05/30/24 - 11:30 am
BridgeBio Pharma
acoramidis
clinical trials
ATTR-CM
FDA grants IND clearance for Spinogenix’s ALS treatment trial
Clinical Trials Arena
Thu, 05/30/24 - 11:13 am
Spinogenix
ALS
clinical trials
SPG302
FDA
Arrowhead's much-anticipated cholesterol drug hits the mark again in phase 2 hyperlipidemia trial
Fierce Biotech
Thu, 05/30/24 - 11:04 am
Arrowhead Pharmaceuticals
clinical trials
hyperlipidemia
plozasiran
J&J's depression treatment succeeds in late-stage study
Yahoo/Reuters
Wed, 05/29/24 - 11:45 am
JNJ
major depressive disorder
clinical trials
seltorexant
Insmed’s shares double as lung disease med powers past expectations in phase 3
Fierce Biotech
Tue, 05/28/24 - 10:57 am
Insmed
bronchiectasis
clinical trials
brensocatib
Nippon Shinyaku’s DMD drug fails confirmatory trial
Pharmaphorum
Tue, 05/28/24 - 10:42 am
Nippon Shinyaku
DMD
Viltepso
clinical trials
ASCO24: Regeneron’s Bispecific Antibody Falls Flat in Early Study
BioSpace
Fri, 05/24/24 - 11:35 am
ASCO 2024
Regeneron
clinical trials
bispecific antibodies
REGN7075
solid tumors
ASCO24: Nimbus Plots Path for Next-Gen IO Therapies with Strong Early HPK1 Blocker Data
BioSpace
Fri, 05/24/24 - 11:31 am
ASCO 2024
Nimbus Therapeutics
NDI-101150
solid tumors
clinical trials
ASCO 2024: Verastem’s combo therapy for pancreatic cancer hits early trial success
Clinical Trials Arena
Fri, 05/24/24 - 11:25 am
ASCO 2024
Verastem
avutometinib
pancreatic cancer
clinical trials
ASCO24: J&J Reports Four Patient Deaths in Early-Stage Prostate Cancer Trial
BioSpace
Fri, 05/24/24 - 11:20 am
ASCO 2024
JNJ
JNJ-6420
prostate cancer
clinical trials
patient deaths
radiopharmaceuticals
89bio CMO touts advantages of pegozafermin following Phase III initiation
Clinical Trials Arena
Thu, 05/23/24 - 11:22 am
89Bio
pegozafermin
MASH
NASH
clinical trials
Sanofi reports positive data from Phase II asthma treatment trial
Clinical Trials Arena
Thu, 05/23/24 - 10:58 am
Sanofi
clinical trials
rilzabrutinib
asthma
Vedanta Biosciences doses first subject in Phase III C difficile prevention trial
Clinical Trials Arena
Wed, 05/22/24 - 11:24 am
Vedanta Biosciences
clinical trials
VE303
C. difficile
Otsuka Drops Alzheimer’s Agitation Drug Following Phase III Failure
BioSpace
Wed, 05/22/24 - 11:20 am
Otsuka
Alzheimer's disease
Alzheimer's agitation
clinical trials
AVP-786
Eli Lilly’s mirikizumab shows promise in Phase III Crohn’s disease trial
Clinical Trials Arena
Wed, 05/22/24 - 11:17 am
Eli Lilly
clinical trials
Crohn's disase
mirikizumab

Pages